- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02614092
Water-based Activity to Enhance Recall in Veterans (WATER-VET)
Water-based Activities to Enhance Recall in Veterans (WATER-VET)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary research question of the proposed study is this: Is a combination water-based physical exercise + cognitive training program for older Veterans with amnestic Mild Cognitive Impairment (MCI) feasible? The primary aims of the proposed research are: 1) demonstrate adequate recruitment and retention rates; 2) refinement of inclusion/exclusion criteria; and 3) further refine the combination waterbased physical exercise + cognitive training (WATER+CT) intervention.
These aims will be tested in a two-phase clinical trial with a single group design: 1) exercise training phase and 2) a cognitive training phase. The exercise training phase consists of a water-based physical exercise program that emphasizes cardiovascular fitness and strength training through a combination of non-weight bearing exercises that include land-based stretching and water-based activities. This 2-year pilot project will include 50 Veterans diagnosed with amnestic MCI age 50-90. The exercise component consists of a six-month water-based exercise program followed by a four-week cognitive training program. For the first two months of the water-based exercise program, Veterans will come to thrice-weekly group sessions at Aquatic Therapy Center at the VA Palo Alto Health Care System. This will transition to a self-paced exercise program for the remaining four months. After completion of the exercise program, Veterans will begin classroom-based cognitive training at the VA Palo Alto Health Care System (VAPAHCS). The cognitive training is based on an efficacious cognitive program that is structured around two components, pre-training and mnemonic training, both of which have been used successfully in persons with aMCI. Assessments of adherence will be administered throughout treatment and measures of feasibility will be completed post-treatment.
Participants will complete a variety of neuropsychological measures taping into areas of cognition such as attention, executive functioning, and memory. To study possible predictors of treatment response, the investigators will also collect biological (cardiovascular functioning and brain derived neurotrophic factor [BDNF] plasma levels) and genetic data (APOE and BDNF genotypes) from these participants. The investigators hope to provide initial evidence of the feasibility of a waterbased exercise training augmentation for cognitive training thus laying the groundwork for full-scale clinical trials targeting the lessening of cognitive impairment in persons with amnestic MCI by non-pharmacological means.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veterans aged 50 - 90
- diagnosis of aMCI
- available informant
- at least one musculoskeletal problem
- sufficient visual and auditory acuity to allow neuropsychological testing
- willingness to participate in exercise training +cognitive training program for eight months
- approval of primary provider to participate in an exercise trial
Exclusion Criteria:
current untreated severe psychiatric disorder, such as:
- Bipolar I
- Schizophrenia
- or Major Depressive Disorder, determined by the Mini International Neuropsychiatric Interview (MINI)
- diagnosis of dementia, Clinical Dementia Rating (CDR) > 0.5; modified Hachinski score 4; or delirium
history of neurological disorder, e.g.:
- multiple sclerosis
- seizure disorder
- stroke
history of transient ischemic attacks, or systemic illness affecting central nervous system (CNS) function, e.g.:
- liver failure
- kidney failure
- congestive heart failure
- systemic cancer
acute illness or unstable chronic illness e.g., history of severe liver disease
- cirrhosis
- esophageal
- varices
- ascites
- portal hypertension
- hepatic encephalopathy
current severe cardiac disease, e.g.:
- uncontrolled atrial fibrillation, defined as mean 24 hour heart rate >85 beats/min, or 24 hour maximal ventricular rate >150 beats/min
- uncontrolled ventricular arrhythmias, defined as recurrent ventricular tachycardia > 3 beats in succession, or 24 hour packed cell volume (PVC) count > 20%; active
- pericarditis or myocarditis
- Class III/IV heart failure and / or ejection fraction < 20%
- thrombophlebitis
- pulmonary disease with a drop in O2 Sat with exercise to 90% without oxygen
- embolism within past six months
- inability to participate in an exercise stress test or inability to exercise consistently because of orthopedic or musculoskeletal problems
- morbid obesity (BMI > 39)
- inability to read, verbalize understanding and voluntarily sign the Informed Consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Water based Activity+ Cognitive Training
water-based physical activity + classroom based cognitive training
|
This is an 8 month long two phase intervention.
The first phase consists of 6 months of thrice weekly pool based physical activity occurring at the Palo Alto VA Health Care System.
After completion of the 6 month long water based physical activity, participants transition to a ten session cognitive training program at the Palo Alto VA.
The cognitive training classes are approximately two hours in length and will be spread over ten sessions across 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention and Recruitment Rates
Time Frame: Through Study Completion, an average of 8 months
|
Feasibility will be demonstrated through ratio of enrolled to completed participants
|
Through Study Completion, an average of 8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Delayed Recall of a Word List
Time Frame: Through Study Completion, an average of 8 months
|
Change From Baseline on the Delayed Recall of a Word List at 8 months
|
Through Study Completion, an average of 8 months
|
|
Participant Adherence to Protocol
Time Frame: Through Study Completion, an average of 8 months
|
Participant completion of study related measurements including pedometers, activity logs, cognitive training homework
|
Through Study Completion, an average of 8 months
|
|
Appropriateness of Inclusion and Exclusion Criteria
Time Frame: From time of consent until completion of Time 3 assessments, an average of 8 months
|
Number of reported serious and non-serious adverse events reported by participants who were eligible for study participation.
|
From time of consent until completion of Time 3 assessments, an average of 8 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jennifer Kaci Fairchild, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E1884-P
- 12I1-RX001884-01A1 (Other Grant/Funding Number: Department of Veterans Affairs RRD)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
High Point UniversityWake Forest University Health Sciences; Hebrew SeniorLifeRecruitingMild Cognitive Impairment (MCI)United States
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Dr. Schär AG / SPARecruitingMild Cognitive Impairment (MCI)Italy
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Çankırı Karatekin UniversityCompletedMild Cognitive Impairment (MCI)Turkey (Türkiye)
-
University of AlbertaCompleted
-
Friedhelm HummelThe Novartis Foundation; Wyss Center for Bio and Neuroengineering; Clinique Romande... and other collaboratorsCompletedMild Cognitive Impairment (MCI)Switzerland
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)TerminatedAmnestic Mild Cognitive ImpairmentUnited States
Clinical Trials on Water-based Activity + Cognitive Training
-
Federal University of PelotasCompleted
-
University of LouisvilleEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Federal University of PelotasUnknown
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Fundació La Marató... and other collaboratorsCompleted
-
University Medical Centre LjubljanaKRKACompletedCoronary Artery DiseaseSlovenia
-
Universidade da MadeiraCasa de Saúde Câmara PestanaCompletedPsychiatric DisorderPortugal
-
University of LouisvilleUniversity of Leeds; Vanderbilt University; Kentucky Spinal Cord and Head Injury...Enrolling by invitation
-
University Hospital, Clermont-FerrandUniversity of Clermont Auvergne (UCA) / LAPSCONot yet recruiting
-
National Taiwan University HospitalNational Science Council, TaiwanUnknown
-
Bambino Gesù Hospital and Research InstituteRecruitingChildhood Obesity | Obesity and Overweight | Leptin ResistanceItaly